Clinical Trial Update: ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder [NA]

View source ↗

Summary

A clinical trial is evaluating intrinsically photosensitive retinal ganglion cells (ipRGCs) as a biomarker to predict response to transcranial magnetic stimulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Snippet

Sponsor: Polytechnic Institute of Porto | Conditions: Depression - Major Depressive Disorder, Treatment Resistant Depression | NA | Status: NOT_YET_RECRUITING